Short answer
GERON CORP (GERN) filed its Q1 2026 10-Q quarterly report on May 6, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $52M (up 30.9% year over year) with net income of −$4M.
Q1 2026 key financials · XBRL
- Revenue
- $52M
- +30.9% YoY
- Net income
- −$4M
- +81.6% YoY
- Operating margin
- 0.3%
- EPS (diluted)
- −$0.01
- +66.7% YoY
Source: XBRL data from the GERON CORP (GERN) Q1 2026 10-Q on SEC EDGAR. USD.
GERON CORP Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue, YoY change, margins, segment performance, cash flow, and capital deployment not provided
- Near-term outlook and guidance not provided beyond general risk disclaimers
Risk Factors
- Commercial risk: RYTELO revenue $51.8 million in Q1 2026 versus $48.0 million in Q4 2025, with sales trends remaining variable
- Regulatory risk: RYTELO approvals carry post-marketing requirements and commitments, with potential penalties or withdrawal for noncompliance
- Compliance risk: Promotional, anti-kickback, fraud-and-abuse violations could trigger criminal sanctions, civil penalties, or healthcare-program exclusion
- Operational risk: December 2025 restructuring and workforce reduction could disrupt commercialization and exceed expected costs
- Financial risk: Debt-service obligations may constrain operating and financial flexibility and limit RYTELO investment
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other GERON CORP quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.